Business
Neuren receives US FDA meeting feeback for HIE and PTHS
Neuren receives US FDA meeting feeback for HIE and PTHS
About this update from Neuren Pharmaceuticals Limited
[{"type":"text","content":"Neuren Pharmaceuticals Ltd has released a press release. View Attachment","length":252,"tagName":"div"}]